This beneficial spectrum extends from reducing elevated serum levels of hepatic enzymes, such as glutamyltransferase (GGT) and alanine aminotransferase (ALT) (which serve as key indicators of hepatic distress), to potentially preventing the development of liver cirrhosis, chronic hepatitis B and C infections, and nonalcoholic fatty liver disease (NAFLD) [33]. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.